tailieunhanh - Serum and blood based biomarkers for lung cancer screening: A systematic review

Lung cancer is the second most common cancer and the leading cause of cancer death for both men and women. Although low-dose CT (LDCT) is recommended for lung cancer screening in high-risk populations and may decrease lung cancer mortality, there is a need to improve the accuracy of lung cancer screening to decrease overdiagnosis and morbidity. | Serum and blood based biomarkers for lung cancer screening A systematic review

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN